Found 1220 matching trials
Cetuximab Compared to Mitomycin-C and 5-Fluorouracil for Locally Advanced Squamous Cell Carcinomas of the Head and Neck PHASE4 Concomitant radio-chemotherapy has become a standard therapy for advanced s...
Show More Location
Medical University Innsbruck, Department for Radiooncology and Therapeutic Oncology
Learn More & Join Trial
Biomakers in Tissue Samples From Patients With Recurrent and/or Metastatic Squamous Cell Cancer of the Head and Neck Previously Treated With Cisplatin With or Without Cetuximab N/A RATIONALE: Studying samples of tissue from patients with cancer in the labo...
Show More Location
Multiple Locations
Learn More & Join Trial
Reduced-intensity Therapy for Oropharyngeal Cancer in Non-smoking HPV-16 Positive Patients NA Taking into account the excellent prognosis of patients with HPV-positive o...
Show More Location
Radiation Oncology , University of Michigan Health System
Learn More & Join Trial
Radiation, Cetuximab and Pemetrexed With or Without Bevacizumab in Locally Advanced Head and Neck Cancer PHASE2 The purpose of this study is to compare the effects (good and bad) of chemo...
Show More Location
University of Pittsburgh Medical Center
Learn More & Join Trial
Use of Cetuximab for Unresectable or Metastatic Esophageal and Gastric Cancer PHASE2 Purpose: There remains a great need for novel therapeutic agents and treatm...
Show More Location
Massachusetts General Hospital
Learn More & Join Trial
Study in mCRC Patients RAS/BRAF wt Tissue and RAS Mutated LIquid BIopsy to Compare FOLFIRI Plus CetuxiMAb or BevacizumaB PHASE3 This study is a prospective, randomized phase III, to evaluate if in patien...
Show More Status
Active Not Recruiting
Location
Ospedale San Salvatore
Learn More & Join Trial
HSK42360-Na Tablets Combined With Cetuximab With or Without Chemotherapy in BRAF V600-Mutant Metastatic Colorectal Cancer PHASE1 This is a Phase I/II, single-arm, open-label, multi-center study to evaluat...
Show More Location
Beijing Cancer Hospital
Learn More & Join Trial
Neoadjuvant PD-1 Inhibitor Combined With Cetuximab in Operable Locally Advanced HNSCC PHASE2 This is a single-center, single-arm, phase II clinical study to evaluate th...
Show More Location
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Learn More & Join Trial
Preoperative Tislelizumab -Cetuximab - Chemotherapy Followed by Salvage Surgery and Adjuvant Tislelizumab -Cetuximab for Resectable, Locally Recurrent Oral and Oropharyngeal Squamous Cell Carcinoma PHASE2 The purpose of this study is to evaluate the effectiveness and safety of th...
Show More Location
Zhongshan Hospital Fudan University
Learn More & Join Trial
A Study to Evaluate the Safety of INCA33890 in Participants With Advanced or Metastatic Solid Tumors PHASE1 To evaluate the safety, tolerability, and DLTs and determine the MTD and/or...
Show More Location
The Angeles Clinic and Research Institute
Learn More & Join Trial